Combination therapy for the cardiovascular effects of perinatal lead exposure in young and adult rats

Arquivos Brasileiros de Cardiologia

Volumn 103, Issue 3, 2014, Pages 219-230

  Fresneda Gaspar, Andréia ^a,b   Cordellini, Sandra ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b NONE   (Brazil)

Author keywords

Cardiovascular effects; Lead toxicity; Perinatal exposure; Rats

Indexed keywords

ACETIC ACID; ACETYLCHOLINE; ARGININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ENALAPRIL MALEATE; LEAD; LEAD ACETATE; NITROPRUSSIDE SODIUM; NORADRENALIN; NORADRENALIN BITARTRATE; SODIUM CARBONATE; SUCCIMER; URETHAN; ANTIHYPERTENSIVE AGENT; CHELATING AGENT;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR EFFECT; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GLOMERULUS FILTRATION RATE; LACTATION; MALE; NEWBORN; NONHUMAN; PERINATAL DRUG EXPOSURE; PERINATAL LEAD EXPOSURE; PREGNANCY; RAT; SYSTOLIC BLOOD PRESSURE; AGE; ANIMAL; BLOOD; BLOOD PRESSURE; BODY WEIGHT; CARDIOVASCULAR SYSTEM; CHEMICALLY INDUCED; COMPLICATION; DRUG EFFECTS; EVALUATION STUDY; HYPERTENSION; LEAD POISONING; MULTIMODALITY CANCER THERAPY; PRENATAL EXPOSURE; PROCEDURES; TIME; TREATMENT OUTCOME; WISTAR RAT;

AGE FACTORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; ARGININE; BLOOD PRESSURE; BODY WEIGHT; CARDIOVASCULAR SYSTEM; CHELATING AGENTS; COMBINED MODALITY THERAPY; ENALAPRIL; FEMALE; HYPERTENSION; LACTATION; LEAD; LEAD POISONING; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS, WISTAR; SUCCIMER; TIME FACTORS; TREATMENT OUTCOME;

EID: 84907465865     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.5935/abc.20140103     Document Type: Article

References (39)

1. Vaziri ND. Mechanisms of lead-induced hypertension and cardiovascular disease. Am J Physiol Heart Circ Physiol. 2008;295(2):H454-465.
2. Skoczynska A, Juzwa W, Smolik R, Szechinski J, Behal FJ. Response of the cardiovascular system to catecholamines in rats given small doses of lead. Toxicology. 1986;39(3):275-89.
3. Tsao DA, Yu HS, Cheng JT, Ho CK, Chang HR. The change of beta‑adrenergic system in lead-induced hypertension. Toxicol Appl Pharmacol. 2000;164(2):127-133.
4. Marques M, Millás I, Jiménez A, García-Colis C, Rodriguez-Feo JA, Velasco S, et al. Alteration of the soluble guanylate cyclase system in the vascular wall of lead-induced hypertension in rats. J Am Soc Nephrol. 2001;12(12):2594-2600.
5. Purdy RE, Smith JR, Ding Y, Oveisi F, Vaziri ND, Gonick HC. Lead-induced hypertension is not associated with altered vascular reactivity in vitro. Am J Hypertens. 1997;10(9 Pt 1):997-1003.
6. Moreira EG, Rosa GJ, Barros SB, Vassillieff VS, Vassilieff I. Antioxidant defense in rat brain regions after developmental lead exposure. Toxicology. 2001;169(2):145-151.
7. Moreira EG, Vassilieff I, Vassillieff VS. Developmental lead exposure: behavioral alterations in the short and long term. Neurotoxicol Teratol. 2001;23(5):489-495.
8. Khalil-Manesh F, Gonick HC, Weiler EW, Prins B, Weber MA, Purdy RE. Lead‑induced hypertension: possible role of endothelial factors. Am J Hypertens. 1993;6(9):723-729.
9. Watts SW, Chai S, Webb RC. Lead acetate-induced contraction in rabbit mesenteric artery: interaction with calcium and protein kinase C. Toxicology. 1995;99(1-2):55-65.
10. Nava-Ruiz C, Méndez-Armenta M, Ríos C. Lead neurotoxicity: effects on brain nitric oxide synthase. J Mol Histol. 2012;43(5):553-563.
11. Fujiwara Y, Kaji T, Yamamoto C, Sakamoto M, Kozuka H. Stimulatory effect of lead on the proliferation of cultured vascular smooth-muscle cells. Toxicology. 1995;98(1-3):105-110.
12. Kaji T, Fujiwara Y, Hoshino M, Yamamoto C, Sakamoto M, Kozuka H. Inhibitory effect of lead on the proliferation of cultured vascular endothelial cells. Toxicology. 1995;95(1-3):87-92.
13. Flora SJ, Mittal M, Mehta A. Heavy metal induced oxidative stress and its possible reversal by chelation therapy. Indian J Med Res. 2008;128(4):501-523.
14. Flora SJ, Pachauri, V. Chelation in metal intoxication. Int J Environ Res Public Health. 2010;7(7):2745-2788.
15. Sears ME. Chelation: harnessing and enhancing heavy metal detoxification‑-a review. Scientific World Journal. 2013;2013:219840.
16. Khalil-Manesh F, Gonick HC, Weiler EW, Prins B, Weber MA, Purdy R, et al. Effects of chelation treatment with dimercaptosuccinic acid (DMSA) on lead‑related blood pressure changes. Environ Res. 1994;65(1):86-99.
17. Cory-Slechta DA. Mobilization of lead over the course of DMSA chelation therapy and long term efficacy. J Pharmacol Exp Ther. 1988;246(1):84-91.
18. Mayer B, Hemmes B. Biosynthesis and action of nitric oxide in mammalian cells. Trends Biochem Sci. 1997;22(12):477-481.
19. Wang J, Wu J, Zhang Z. Oxidative Stress in mouse brain exposed to lead. Ann Occup Hyg. 2006;50(4):405-409.
20. Athanasopoulos, N. Flame Methods Manual GBC for Atomic Absorption. Australia: Vitoria; 1994. p. 1-11.
21. Agency for Toxic Substances & Diseases Registry. (ATSDR). Toxicological profile for lead [Internet]. Atlanta: ATSDR; 2007 [Cited on 2014 Apr 2]. Available from: http://www.atsdr.cdc.gov/toxprofiles/tp.asp?id=96&tid=22.
22. Kopp SJ, Barron JT, Tow JP. Cardiovascular actions of lead and relationship to hypertension: a review. Environ Health Perspect. 1988;78:91-99.
23. Vaziri ND, Gonick HC. Cardiovascular effects of lead exposure. Indian J Med Res. 2008;128(4):426-435.
24. Malvezzi CK, Moreira EG, Vassilieff I, Vassilieff VS, Cordellini S. Effect of L-arginine, dimercaptosuccinic acid (DMSA) and the association of L-arginine and DMSA on tissue lead mobilization and blood pressure level in plumbism. Braz J Med Biol Res. 2001;34(10):1341-6.
25. Heydari A, Norouzzadeh A, Khoshbaten A, Asgari A, Ghasemi A, Najafi S, et al. Effects of short-term and subchronic lead poisoning on nitric oxide metabolites and vascular responsiveness in rat. Toxicol Lett. 2006;166(1):88-94.
26. Patrick L. Lead toxicity, a review of the literature. Part 1: Exposure, evaluation, and treatment. Altern Med Rev. 2006;11(1):2-22.
27. Grizzo LT, Cordellini S. Perinatal lead exposure affects nitric oxide and cyclooxygenase pathways in aorta of weaned rats. Toxicol Sci. 2008;103(1):207-14.
28. Weiler E, Khalil-Manesh F, Gonick HC. Effects of lead and low-molecular-weight endogenous plasma inhibitor on the kinetics of sodium-potassium-activated adenosine triphosphatase and potassium-activated p-nitrophenylphosphatase. Clin Sci. 1990;79(2):185-192.
29. Hart WM Jr, Titus EO. Sulfhydryl groups of sodium-potassium transport adenosine triphosphatase. J Biol Chem. 1973;248(13):4674-4681.
30. Kalia K, Flora SJ. Strategies for safe and effective therapeutic measures for chronic arsenic and lead poisoning. J Occup Health. 2005;47(1):1-21.
31. Hamidinia SA, Erdahl WL, Chapman CJ, Steinbaugh GE, Taylor RW, Pfeiffer DR. Monensin improves the effectiveness of meso-dimercaptosuccinate when used to treat lead intoxication in rats. Environ Health Perspect. 2006;114(4):484-493.
32. Kachru DN, Khandelwal S, Tandon SK. Influence of methionine supplementation in chelation of lead in rats. Biomed Environ Sci. 1989;2(3):265-270.
33. Quig D. Cysteine metabolism and metal toxicity. Altern Med Rev. 1998;3(4):262-270.
34. Drapier JC, Bouton C. Modulation by nitric oxide of metalloprotein regulatory activities. Bioessays. 1996;18(7):549-556.
35. Misra RR, Hochadel JF, Smith GT, Cook JC, Waalkes MP, Wink DA. Evidence that nitric oxide enhances cadmium toxicity by displacing the metal from metallothionein. Chem Res Toxicol. 1996;9(1):326-332.
36. Ng HY, Tain YL, Lee YT, Hsu CY, Chiou TT, Huang PC, et al. Renin angiotensin system blockade ameliorates lead nephropathy. Biochem Biophys Res Commun. 2013;438(2):359-63.
37. Ding Y, Vaziri ND, Gonick HC. Lead-induced hypertension II. Response to sequential infusions of L-arginine, superoxide dismutase, and nitroprusside. Environ Res. 1998;76(2):107-113.
38. Pappas JB, Nuttall KL, Ahlquist JT, Allen EM, Banner W Jr. Oral dimercaptosuccinic acid and ongoing exposure to lead: effects on heme synthesis and lead distribution in a rat model. Toxicol Appl Pharmacol. 1995;133(1):121-129.
39. Patrick L. Lead toxicity part II: the role of free radical damage and the use of antioxidants in the pathology and treatment of lead toxicity. Altern Med Rev. 2006;11(2):114-127.